Alector
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Alector and other ETFs, options, and stocks.About ALEC
Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology. It develops portfolio of innate immune system programs, designed to functionally repair genetic mutations and enable the rejuvenated immune cells to counteract emerging brain pathologies.
CEOArnon Rosenthal
CEOArnon Rosenthal
Employees238
Employees238
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2013
Founded2013
Employees238
Employees238
ALEC Key Statistics
Market cap153.90M
Market cap153.90M
Price-Earnings ratio-1.31
Price-Earnings ratio-1.31
Dividend yield—
Dividend yield—
Average volume1.85M
Average volume1.85M
High today$1.45
High today$1.45
Low today$1.35
Low today$1.35
Open price$1.37
Open price$1.37
Volume3.00M
Volume3.00M
52 Week high$3.40
52 Week high$3.40
52 Week low$0.87
52 Week low$0.87
Stock Snapshot
The current Alector(ALEC) stock price is $1.41, with a market capitalization of 153.9M. The stock trades at a price-to-earnings (P/E) ratio of -1.31.
As of 2025-12-21, Alector(ALEC) stock has fluctuated between $1.35 and $1.45. The current price stands at $1.41, placing the stock +4.4% above today's low and -2.8% off the high.
Alector(ALEC) shares are trading with a volume of 3M, against a daily average of 1.85M.
In the last year, Alector(ALEC) shares hit a 52-week high of $3.40 and a 52-week low of $0.87.
In the last year, Alector(ALEC) shares hit a 52-week high of $3.40 and a 52-week low of $0.87.
Analyst ratings
63%
of 8 ratingsBuy
12.5%
Hold
62.5%
Sell
25%
People also own
Based on the portfolios of people who own ALEC. This list is generated using Robinhood data, and it’s not a recommendation.